Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Comorbidity adjustment is an important component of health services research and clinical prognosis. When adjusting for comorbidities in statistical models, researchers can include comorbidities individually or through the use of summary measures such as the Charlson Comorbidity Index or Elixhauser score. We examined the conditions under which individual versus summary measures are most appropriate. METHODS: We provide an analytic proof of the utility of comorbidity summary measures when used in place of individual comorbidities. We compared the use of the Charlson and Elixhauser scores versus individual comorbidities in prognostic models using a SEER-Medicare data example. We examined the ability of summary comorbidity measures to adjust for confounding using simulations. RESULTS: We devised a mathematical proof that found that the comorbidity summary measures are appropriate prognostic or adjustment mechanisms in survival analyses. Once one knows the comorbidity score, no other information about the comorbidity variables used to create the score is generally needed. Our data example and simulations largely confirmed this finding. CONCLUSIONS: Summary comorbidity measures, such as the Charlson Comorbidity Index and Elixhauser scores, are commonly used for clinical prognosis and comorbidity adjustment. We have provided a theoretical justification that validates the use of such scores under many conditions. Our simulations generally confirm the utility of the summary comorbidity measures as substitutes for use of the individual comorbidity variables in health services research. One caveat is that a summary measure may only be as good as the variables used to create it.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
The central role of the propensity score in observational studies for causal effects
ROSENBAUM, P. R., & RUBIN, D. B. (1983) · Biometrika · doi:10.1093/biomet/70.1.41 · Cited by 31,241
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452 · cited 1×
“Although initially developed for use with medical records data, the Charlson Comorbidity Index has been adapted for use with health claims data.(5,6,9) The validity of the Charlson Comorbidity Index as well as its adaptations have been investigated in multiple studies.”
MethodComorbidity measures for use with administrative data.
Elixhauser, A., Steiner, C., Harris, D. R., & Coffey, R. M. (1998) · Medical Care · doi:10.1097/00005650-199801000-00004 · Cited by 9,921 · cited 1×
“When adjusting for comorbidities, researchers may consider comorbidities individually or through the use of summary measures such as the Charlson Comorbidity Index or the Elixhauser comorbidity measures.(7,8) In statistical models, investigators might incorporate comorbidities, such as diabetes or heart disease, by in…”
MethodHarrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Reducing Bias in Observational Studies Using Subclassification on the Propensity Score
Rosenbaum, P. R., & Rubin, D. B. (1984) · Journal of the American Statistical Association · doi:10.1080/01621459.1984.10478078 · Cited by 3,082 · cited 2×
“This demonstrates that a comorbidity score derived from a multiple linear regression when used in a subsequent multiple linear regression is similar to a balancing score such as the propensity score.(20,21) TABLE 6.”
BackgroundMethodvan Walraven, C., Austin, P. C., Jennings, A., Quan, H., & Forster, A. J. (2009) · Medical Care · doi:10.1097/mlr.0b013e31819432e5 · Cited by 2,200 · cited 3×
“As an additional example, we also investigate properties of the more recently developed Elixhauser score.(8) From the *Whiting School of Engineering Undergraduate Student, Johns Hopkins University, Baltimore, MD; Departments of wMedical Oncology; zSurgery, Fox Chase Cancer Center; yAcademic Affairs, Fox Chase Cancer C…”
MethodDevelopment of a comorbidity index using physician claims data
Klabunde, C. N., Potosky, A. L., Legler, J. M., & Warren, J. L. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00256-0 · Cited by 1,845
Sangha, O., Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (2003) · Arthritis Care & Research · doi:10.1002/art.10993 · Cited by 1,806
Cited by
Charlson Comorbidity Index: A Critical Review of Clinimetric Properties
Charlson, M. E., Carrozzino, D., Guidi, J., & Patierno, C. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000521288 · Cited by 1,686
Moore, B. J., White, S., Washington, R., Coenen, N., & Elixhauser, A. (2017) · Medical Care · doi:10.1097/mlr.0000000000000735 · Cited by 827
The Charlson Comorbidity Index in Registry-based Research: Which Version to Use?
Lagergren, J., & Brusselaers, N. (2017) · Methods of Information in Medicine · doi:10.3414/me17-01-0051 · Cited by 337
Tuty Kuswardhani, R. A., Henrina, J., Pranata, R., Anthonius Lim, M., Lawrensia, S., & Suastika, K. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.10.022 · Cited by 294
Regression coefficient–based scoring system should be used to assign weights to the risk index
Mehta, H. B., Mehta, V., Girman, C. J., Adhikari, D., & Johnson, M. L. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.03.031 · Cited by 222
Early‐ and later‐stage persistence with antiobesity medications: A retrospective cohort study
Gasoyan, H., Pfoh, E. R., Schulte, R., Le, P., & Rothberg, M. B. (2024) · Obesity · doi:10.1002/oby.23952 · Cited by 94
Boscarino, J. A., Lu, M., Moorman, A. C., Gordon, S. C., Rupp, L. B., Spradling, P. R., Teshale, E. H., Schmidt, M. A., Vijayadeva, V., Holmberg, S. D., et al. (2015) · Hepatology · doi:10.1002/hep.27422 · Cited by 75
“Based on previous research, the Charlson Comorbidity Index was used to categorize patients into no score, low score, moderate score, or high score results.(33) Statistical Methods.”
One-Year Weight Reduction With Semaglutide or Liraglutide in Clinical Practice
Gasoyan, H., Pfoh, E. R., Schulte, R., Le, P., Butsch, W. S., & Rothberg, M. B. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.33326 · Cited by 71
Standl, E., Stevens, S. R., Lokhnygina, Y., Bethel, M. A., Buse, J. B., Gustavson, S. M., Maggioni, A. P., Mentz, R. J., Hernandez, A. F., & Holman, R. R. (2020) · Diabetes Care · doi:10.2337/dc19-1079 · Cited by 65
“diabetes (years) 12 (7, 17) 14 (9, 22) 16 (11, 22) 17 (10, 24) 12 (7, 18)”
MethodInfluentialGasoyan, H., Butsch, W. S., Schulte, R., Casacchia, N. J., Le, P., Boyer, C. B., Griebeler, M. L., Burguera, B., & Rothberg, M. B. (2025) · Obesity · doi:10.1002/oby.24331 · Cited by 54
“Age-adjusted Charlson Comorbidity Index was also captured from the electronic health record [18].”
Gasoyan, H., Pfoh, E. R., Schulte, R., Sullivan, E., Le, P., & Rothberg, M. B. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15473 · Cited by 41
Radwan, R. M., Lee, Y. A., Kotecha, P., Wright, D. R., Hernandez, I., Ramon, R., Donahoo, W. T., Chen, Y., Allen, J. M., Bian, J., et al. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16318 · Cited by 24
Metadata
- Authors
- Austin, S. R., Wong, Y.-N., Uzzo, R. G., Beck, J. R., & Egleston, B. L.
- Venue
- Medical Care
- Published
- 2015-09
- Volume
- 53
- Issue
- 9
- Pages
- e65-e72
- ISSN
- 0025-7079 (ISSN-L)
- OpenAlex
- W2064691418
- Cited by
- 716
- References
- 24
- FWCI
- 7.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.